FDA Approves Durvalumab for Limited-Stage Small Cell Lung Cancer By Ogkologos - January 17, 2025 725 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the ADRIATIC study Source RELATED ARTICLESMORE FROM AUTHOR Solid Organ Transplant Recipients with Pretransplant Cancer Have an Elevated Risk of Posttransplant Cancer of the Same Cancer Type Population-based lung cancer screening can reduce mortality in people who have never smoked, study shows in China EMA Recommends Granting a Conditional Marketing Authorisation for Tovorafenib MOST POPULAR The future of research: meet three of our scientists working on... December 13, 2022 NCI Expands Repository of Cancer Research Models: A Conversation with Drs.... April 20, 2018 Vegetarian Recipes September 4, 2020 FDA Grants Accelerated Approval to Dostarlimab-gxly for dMMR Advanced Solid Tumours August 20, 2021 Load more HOT NEWS Mom Walks In To Comfort Scared Son After Surgery And Sees... Heine H. Hansen Award: Johan Vansteenkiste and Fiona Blackhall Honoured for... Patients with Breast, Colorectal, and Pancreatic Cancers With ATM, CHEK2, or... 11 Children Orphaned and Unable to Pay for Funeral After Their...
